Results 221 to 230 of about 84,205 (294)

On why cancer cells require a great amount of glucose

open access: yesQuantitative Biology, Volume 14, Issue 2, June 2026.
Abstract The traditional thinking has been that cancer cells require a great amount of glucose to support their rapid growth, but the reality may be different. We have previously demonstrated that all cancer cells in The Cancer Genome Atlas harbor persistent Fenton reactions in their cytosol, which generate OH− ${\text{OH}}^{-}$ and ultimately kill the
Xuechen Mu   +6 more
wiley   +1 more source

Endogenous Competition Strategies With R&D in a Vertically Mixed Market Under Forward Passive Ownership

open access: yesThe Manchester School, Volume 94, Issue 2, Page 234-248, March 2026.
ABSTRACT This study examines endogenous choices of competition strategies in a vertically related mixed market in which an integrated public firm and a downstream firm, subject to forward passive ownership (FPO) by an input supplier, may engage in R&D investment.
Lili Xu, Yidan Zhang, Sang‐Ho Lee
wiley   +1 more source

Enhanced Water Harvesting on Directionally Patterned Slippery Undecylenic‐Modified Cellulose Nanoparticle Surfaces

open access: yesAdvanced Materials Interfaces, Volume 13, Issue 3, 3 February 2026.
Bioinspired slippery surfaces combining the hydrophobic–hydrophilic patterns of beetle backs and the lubricated structure of pitcher plants enable efficient water harvesting. The patterned hydrophilic regions promote droplet nucleation and coalescence, while the infused lubricant ensures rapid droplet transport, providing a robust strategy for ...
Wei Huang   +7 more
wiley   +1 more source

Fushun to invest in Liaoning park

open access: yesFocus on Catalysts, 2003
openaire   +1 more source

The safety of trastuzumab deruxtecan (T‐DXd) in breast cancer brain metastases with a focus on interstitial lung disease/pneumonitis: A systematic review and meta‐analysis

open access: yesCancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Although trastuzumab deruxtecan (T‐DXd) demonstrated unprecedented intracranial efficacy in HER2‐positive breast cancer brain metastases (BCBM), its association with interstitial lung disease (ILD)/pneumonitis posed a critical safety concern in this high‐risk population.
Yiwen Ma   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy